Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme
<p>Abstract</p> <p>Background</p> <p>Insulin-degrading enzyme (IDE) is a widely studied zinc-metalloprotease implicated in the pathogenesis of type 2 diabetes mellitus, Alzheimer disease (AD) and varicella zoster virus infection. Despite more than six decades of research on IDE, progress has been ha...
Gorde:
| Egile Nagusiak: | , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2009-10-01
|
| Saila: | Molecular Neurodegeneration |
| Sarrera elektronikoa: | http://www.molecularneurodegeneration.com/content/4/1/39 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|